Innovative Eyewear, Inc. (LUCY)
USD 5.55
(-7.65%)
USD 5.55
(-7.65%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 659.93 Thousand USD | -0.83% |
| 2022 | 665.45 Thousand USD | 7.89% |
| 2021 | 616.8 Thousand USD | -19.46% |
| 2020 | 765.85 Thousand USD | 58.29% |
| 2019 | 483.82 Thousand USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 515.08 Thousand USD | -43.49% |
| 2024 Q1 | 911.44 Thousand USD | 38.11% |
| 2023 FY | 659.93 Thousand USD | -0.83% |
| 2023 Q2 | 388.54 Thousand USD | -30.94% |
| 2023 Q1 | 562.59 Thousand USD | -15.46% |
| 2023 Q4 | 659.93 Thousand USD | 39.32% |
| 2023 Q3 | 473.68 Thousand USD | 21.91% |
| 2022 Q2 | 2.45 Million USD | 49.28% |
| 2022 Q1 | 1.64 Million USD | 166.45% |
| 2022 FY | 665.45 Thousand USD | 7.89% |
| 2022 Q4 | 665.45 Thousand USD | -21.81% |
| 2022 Q3 | 851.04 Thousand USD | -65.31% |
| 2021 Q2 | 410.65 Thousand USD | 0.0% |
| 2021 FY | 616.8 Thousand USD | -19.46% |
| 2021 Q1 | - USD | -100.0% |
| 2021 Q4 | 616.8 Thousand USD | -7.33% |
| 2021 Q3 | 665.59 Thousand USD | 62.08% |
| 2020 Q4 | 765.85 Thousand USD | 0.0% |
| 2020 FY | 765.85 Thousand USD | 58.29% |
| 2019 FY | 483.82 Thousand USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 126.59 Million USD | 99.479% |
| AngioDynamics, Inc. | 112.08 Million USD | 99.411% |
| AtriCure, Inc. | 147.76 Million USD | 99.553% |
| Avinger, Inc. | 19.97 Million USD | 96.696% |
| Azenta, Inc. | 351.22 Million USD | 99.812% |
| BioLife Solutions, Inc. | 75.05 Million USD | 99.121% |
| The Cooper Companies, Inc. | 4.1 Billion USD | 99.984% |
| Daxor Corporation | 858.75 Thousand USD | 23.152% |
| Ekso Bionics Holdings, Inc. | 16.31 Million USD | 95.954% |
| Femasys Inc. | 9.4 Million USD | 92.982% |
| GlucoTrack, Inc. | 1.7 Million USD | 61.362% |
| Harvard Bioscience, Inc. | 64.29 Million USD | 98.974% |
| Hologic, Inc. | 4.02 Billion USD | 99.984% |
| ICU Medical, Inc. | 2.25 Billion USD | 99.971% |
| Intuitive Surgical, Inc. | 2.04 Billion USD | 99.968% |
| KORU Medical Systems, Inc. | 8.1 Million USD | 91.86% |
| LeMaitre Vascular, Inc. | 48.87 Million USD | 98.65% |
| Innovative Eyewear, Inc. | 659.93 Thousand USD | 0.0% |
| Masimo Corporation | 1.67 Billion USD | 99.961% |
| Microbot Medical Inc. | 3.82 Million USD | 82.751% |
| Meihua International Medical Technologies Co., Ltd. | 25.07 Million USD | 97.368% |
| Merit Medical Systems, Inc. | 1.12 Billion USD | 99.941% |
| Nephros, Inc. | 3.5 Million USD | 81.161% |
| NovoCure Limited | 783.63 Million USD | 99.916% |
| NEXGEL, Inc. | 4.78 Million USD | 86.22% |
| NEXGEL, Inc. | 4.78 Million USD | 86.22% |
| Singular Genomics Systems, Inc. | 86.46 Million USD | 99.237% |
| OraSure Technologies, Inc. | 52.17 Million USD | 98.735% |
| Pro-Dex, Inc. | 23.34 Million USD | 97.173% |
| Pulse Biosciences, Inc. | 16.44 Million USD | 95.987% |
| Predictive Oncology Inc. | 6.14 Million USD | 89.261% |
| Precision Optics Corporation, Inc. | 6.84 Million USD | 90.359% |
| QuidelOrtho Corporation | 3.55 Billion USD | 99.981% |
| Repligen Corporation | 853.2 Million USD | 99.923% |
| Sanara MedTech Inc. | 29.28 Million USD | 97.746% |
| STAAR Surgical Company | 102.73 Million USD | 99.358% |
| Sharps Technology, Inc. | 3.85 Million USD | 82.881% |
| Utah Medical Products, Inc. | 7.14 Million USD | 90.764% |
| DENTSPLY SIRONA Inc. | 4.07 Billion USD | 99.984% |
| Jin Medical International Ltd. | 8.92 Million USD | 92.605% |